Richards, Merrill & Peterson’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Sell
15,030
-493
-3% -$57.7K 0.61% 39
2026
Q1
$1.87M Sell
15,523
-357
-2% -$41.2K 0.69% 37
2025
Q4
$1.67M Sell
15,880
-183
-1% -$17.2K 0.64% 40
2025
Q3
$1.35M Sell
16,063
-226
-1% -$18.6K 0.58% 44
2025
Q2
$1.29M Buy
16,289
+24
+0.1% +$1.91K 0.61% 46
2025
Q1
$1.46M Sell
16,265
-1,018
-6% -$95K 0.76% 31
2024
Q4
$1.72M Buy
+17,283
New +$1.78M 0.9% 23

Other funds holding MRK

Richards, Merrill & Peterson's MRK Position: Q2 2026 in Review

Richards, Merrill & Peterson reduced its Merck (MRK) stake by 3.2% in Q2 2026, selling an estimated $57.7K and leaving 15,030 shares worth $1.93M. The position accounts for 0.61% of the portfolio, ranked #39.

Richards, Merrill & Peterson first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,687 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Richards, Merrill & Peterson held 15,030 shares of Merck worth $1.93M as of Q2 2026.
  • Richards, Merrill & Peterson sold 493 Merck shares in Q2 2026, an estimated $57.7K.
  • Merck made up 0.61% of Richards, Merrill & Peterson's portfolio in Q2 2026, its #39 holding.
  • Richards, Merrill & Peterson first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2026, filed 16 Jul 2026.